Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of pirfenidone for novel coronavirus pneumonia/pneumonia is in unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Novel Coronavirus Pneumonia
• Pneumonia

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Huilan Zhang | Conditions: Novel Coronavirus Pneumonia, Pneumonia | Phase 3 | Status: UNKNOWN